spacer
home > pmps > autumn 2018 > managing medication
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Managing Medication

Medication nonadherence is a serious public health issue. It costs the NHS approximately £500 million every year, as well as countless hours of work dealing with problems which arise due to patients not taking prescribed medications as directed. As the former US general surgeon, Dr C Everett Koop, stated, “drugs don’t work in patients who don’t take them.”

Across the UK, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of the True Cost of Medication Non- Adherence report admitted to not taking their medication as prescribed. “Non-adherence is a big problem,” Ric Fordham, Professor of Applied Health and Economics at the University of East Anglia, UK, said in the study. “When patients don’t feel ill, or they start to feel better, they think there is no need for them to take their drugs anymore. Patients then don’t get the full benefit of them and that ends up reducing the cost effectiveness of the drugs.”

Nonadherence can be classified as intentional (when a patient actively decides not to take medication or follow treatment recommendations) or unintentional (which can be caused by misunderstanding the prescription requirements, an inability to access or administer prescribed medication, or simple forgetfulness). The National Institute for Health and Care Excellence states that nonadherence should not be considered as just the patient’s problem; ultimately, it represents a fundamental limitation in the delivery of healthcare.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Oliver Pittock is the Managing Director of pharmaceutical packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Realising the potential of single-use technology – As published in Manufacturing Chemist

In this article Zenith Technologies’ Global Director of Managed Services David Staunton and Scott Ripley, Global Marketing Director at GE Healthcare, discuss the benefits and patient impact of single-use technology with Manufacturing Chemist.
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

 
Industry Events

World Advanced Therapies & Regenerative Medicine Congress 2019

15-17 May 2019, Business Design Centre, London

The World Advanced Therapies & Regenerative Medicine Congress is an exhibition and conference that has grown to become one of the best and most established cell and gene events in the world today.     The 2019 edition will be in its 14th year and it continues to grow and attract a large audience of biotech, pharma, start-ups, investors, research and technology companies from around the world. The conference and exhibition will host over 1000 attendees, 250 speakers and 80 exhibition booths. Over 500 different global companies are represented every year at this event. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement